In diabetes-caused cardiac myopathy, TQ treatment (50 mg/kg/day for 12 weeks, by gavage,) resulted in decreased plasma and tissue MDA levels (lipid peroxidation index) as well as increased plasma SOD activity and increased cardiac tissue expression. This evidence concerns the gene SOD1 and diabetes mellitus.